Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.130
+0.010 (0.89%)
At close: Nov 28, 2025, 1:00 PM EST
1.120
-0.010 (-0.88%)
After-hours: Nov 28, 2025, 4:28 PM EST
Tenon Medical Revenue
Tenon Medical had revenue of $1.17M in the quarter ending September 30, 2025, with 32.24% growth. This brings the company's revenue in the last twelve months to $3.23M, down -2.47% year-over-year. In the year 2024, Tenon Medical had annual revenue of $3.28M with 11.92% growth.
Revenue (ttm)
$3.23M
Revenue Growth
-2.47%
P/S Ratio
2.00
Revenue / Employee
$119,741
Employees
27
Market Cap
9.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.28M | 349.00K | 11.92% |
| Dec 31, 2023 | 2.93M | 2.24M | 323.73% |
| Dec 31, 2022 | 691.00K | 531.00K | 331.88% |
| Dec 31, 2021 | 160.00K | 116.18K | 265.13% |
| Dec 31, 2020 | 43.82K | -9.82K | -18.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TNON News
- 14 days ago - Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing - Accesswire
- 15 days ago - Tenon Medical, Inc. (TNON) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Tenon(R) Medical Reports Third Quarter 2025 Financial Results - Accesswire
- 17 days ago - Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing - Accesswire
- 25 days ago - Tenon Medical, Inc. Announces Timing of Third Quarter 2025 Financial Results - Accesswire
- 5 weeks ago - Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System - Accesswire
- 3 months ago - Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months - Accesswire
- 3 months ago - Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System - Accesswire